J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MORRISSEY, I.
Right arrow Articles by MATHIAS, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MORRISSEY, I.
Right arrow Articles by MATHIAS, I.
Agricola
Right arrow Articles by MORRISSEY, I.
Right arrow Articles by MATHIAS, I.
J. Med. Microbiol. -- Vol. 49 (2000), 841-844
© 2000 Society for General Microbiology
ISSN 0022-2615

ANTIMICROBIAL AGENTS

The bactericidal activity of gemifloxacin (SB-265805)

I. MORRISSEY, S. CLARK and I. MATHIAS

GR Micro Ltd, 7–9 William Road, London NW1 3ER

Corresponding author: Dr I. Morrissey (e-mail: i.morrissey{at}grmicro.co.uk).

Received 14 Sept. 1999; revised version accepted 10 Feb. 2000.

Abstract

The bactericidal activity and mechanisms of action of the new fluoroquinolone gemifloxacin were investigated against the laboratory strains Escherichia coli KL16, Staphylococcus aureus E3T and Streptococcus pneumoniae C3LN4. Gemifloxacin was found to be highly bactericidal against these bacteria, producing a biphasic dose- response curve typical of the fluoroquinolones. This novel fluoroquinolone was more bactericidal than all other fluoroquinolones so far tested (ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, levofloxacin, clinafloxacin, trovafloxacin, DV-7751 and sitafloxacin) against S. aureus and was more bactericidal than most other fluoroquinolones against E. coli or Str. pneumoniae. These data show gemifloxacin to be an improved member of the fluoroquinolone class of antibacterial agents.




This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
S. J. Beard, V. Salisbury, R. J. Lewis, J. A. Sharpe, and A. P. MacGowan
Expression of lux Genes in a Clinical Isolate of Streptococcus pneumoniae: Using Bioluminescence To Monitor Gemifloxacin Activity
Antimicrob. Agents Chemother., February 1, 2002; 46(2): 538 - 542.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2000 Society for General Microbiology.